The global custom antibody market is poised for significant growth, with projections indicating it will reach USD 901 million by 2029, up from USD 579 million in 2024, at a compound annual growth rate (CAGR) of 9.2% during the forecast period.
Download an Illustrative overview:
The market encompasses a wide range of data and insights, detailed across 376 pages, including 472 market data tables and 52 figures. The comprehensive report, "Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029," provides an in-depth analysis.
Market Dynamics:
The surge in biomedical and clinical research, particularly within academia and research institutions, is driving the demand for custom antibodies. Advances in biotechnology and genetic engineering have enhanced the development and production of these antibodies, improving their specificity and efficacy. Additionally, the biopharmaceutical industry’s growing emphasis on biologics and biosimilars is fueling this demand.
Key Segments:
- Service Segments: In 2023, the antibody development segment held the largest share. This segment includes antigen preparation, immunization & hybridoma production, and antibody characterization, driven by the rise in personalized medicine, which necessitates antibodies tailored to individual patient profiles.
- Type Segments: Monoclonal antibodies led the market in 2023, with the segment anticipated to grow at the highest CAGR. Their high specificity and affinity for targets make them effective in treating various diseases, including cancer, autoimmune disorders, and infectious diseases.
- Source Segments: The mice segment, accounting for the largest share in 2023, is expected to grow at a higher rate due to the cost-effectiveness and efficiency of using mice for large-scale antibody production.
- Indication Segments: Oncology held the largest share in 2023. Numerous approved monoclonal antibody therapies are designed for cancer treatment, including immune checkpoint inhibitors and antibody-drug conjugates (ADCs).
- Regional Insights: North America led the market in 2023, driven by substantial investments in drug discovery and development, as well as government and private funding for biopharmaceutical research.
Key Players:
Major players in the custom antibody market include Thermo Fisher Scientific Inc. (US), GenScript (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), and many others, reflecting the competitive landscape and diverse expertise across the sector.
Content Source:
https://www.marketsandmarkets.com/PressReleases/custom-antibody.asp
https://www.marketsandmarkets.com/ResearchInsight/custom-antibody-market.asp
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
